GLENN PIERCE
CIK 1256964 · Interim CSO · last filed 2026-06-11
GLENN PIERCE is an Interim CSO who has filed 25 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for VYGR, was dated Jun 11, 2026. Across all open-market trades the lifetime net is +$28.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $76.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$76.3K
2
25
$28.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VYGR | Director | 21,788 | $3.50 | $76.3K | $28.5K | 15 | 2026-06-11 |
| Global Blood Therapeutics, Inc. (GBT) Delisted | Director | 0 | $68.49 | $0 | $0 | 10 | 2022-10-06 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | VYGR | Grant (A) | — | $0 | EDGAR |
| 2025-06-04 | VYGR | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | VYGR | Grant (A) | — | $0 | EDGAR |
| 2023-06-07 | VYGR | Grant (A) | — | $0 | EDGAR |
| 2022-10-06 | Global Blood Therapeutics, Inc. (GBT) Delisted | Disp (D) | −26,437 | $0 | EDGAR |
| 2022-07-18 | VYGR | Sell (S) | −9,512 | -$63.7K | EDGAR |
| 2022-06-16 | Global Blood Therapeutics, Inc. (GBT) Delisted | Mixed | +3,600 | $0 | EDGAR |
| 2022-06-08 | VYGR | Grant (A) | — | $0 | EDGAR |
| 2022-01-18 | VYGR | Grant (A) | +26,300 | $0 | EDGAR |
| 2021-06-21 | Global Blood Therapeutics, Inc. (GBT) Delisted | Mixed | +3,037 | $0 | EDGAR |